Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Regeneron and SocietyforScience
Shared 4 days ago
488 views
Regeneron and SocietyforScience
Shared 2 weeks ago
664 views
Shared 1 month ago
428K views
Regeneron and SocietyforScience
Shared 1 month ago
1.8K views
Shared 1 month ago
135 views
Shared 1 month ago
53 views
Shared 2 months ago
88 views
Shared 2 months ago
222 views
Shared 3 months ago
204 views
Shared 4 months ago
310 views
Shared 4 months ago
124 views
Shared 4 months ago
41K views
Shared 4 months ago
160 views
Shared 4 months ago
103K views
Shared 8 months ago
728 views
Shared 8 months ago
143 views
Shared 9 months ago
435 views
Shared 9 months ago
18K views
Shared 9 months ago
23K views
Shared 9 months ago
298 views
Shared 11 months ago
571 views
Shared 11 months ago
393 views
Shared 1 year ago
292 views
Shared 1 year ago
335 views
Shared 1 year ago
388 views
Shared 1 year ago
418 views
Shared 1 year ago
3.3M views
Shared 1 year ago
228 views
Shared 1 year ago
1.6K views
Shared 2 years ago
419K views
Shared 3 years ago
3.1K views
Shared 3 years ago
28K views
Shared 3 years ago
11K views
Shared 3 years ago
28K views